Adrenergic response of splanchnic arteries from cirrhotic patients: Role of nitric oxide, prostanoids, and reactive oxygen species

Experimental Biology and Medicine

Volumn 232, Issue 10, 2007, Pages 1360-1367

  Salcedo, Adely ^a   Garijo, Jesús ^a   Monge, Luis ^a   Fernández, Nuria ^a   García Villalón, Angel Luis ^a   Sánchez Turrión, Víctor ^a   Cuervas Mons, Valentín ^a   Diéguez, Godofredo ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

1 adrenoceptors; 2 adrenoceptors; Hepatic arteries; Prostacyclin; Vasoconstriction

Indexed keywords

CLONIDINE; MECLOFENAMIC ACID; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; YOHIMBINE;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HEPATIC ARTERY; HUMAN; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERY; SPLANCHNIC BLOOD FLOW;

ADULT; AGED; FEMALE; HEPATIC ARTERY; HUMANS; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERIES; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; PHENYLEPHRINE; PROSTAGLANDINS; REACTIVE OXYGEN SPECIES; SPLANCHNIC CIRCULATION;

EID: 35549007724     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0701-RM-112     Document Type: Article

References (29)

1. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20:1359-1363, 1994.
2. Hadoke PWF, Hayes PC. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther 75:51-68, 1997.
3. 1-Adrenergic vascular reactivity is reduced in isolated rings of the hepatic artery and the portal vein from patients with liver cirrhosis. Hepatology 24(Suppl. S, Part 2):315, 1996.
4. Smith RE, Robinson NM, McPeake JR, Baylis SA, Charles IG, Heaton ND, Moncada S, Williams R, Martin JF. Induction and role of NO synthase in hypotensive hepatic failure. Arterioscler Thromb Vasc Biol 17:3079-3082, 1997.
5. Hadoke PWF, Dillon JF, John TG, Walkers SW, Hayes PC, Williams BC. Contractile response of isolated human hepatic arteries to α-adrenoceptor agonists is not impaired in patients with cirrhosis. Clin Sci 95:505-511, 1998.
6. Vaughan RB, Angus JA, Angus PW. Vasoconstrictor responses are normal but prostanoid-mediated vasodilatation in enhanced in human cirrhotic mesenteric arteries. J Gastroenterol Hepatol 20:1158-1164, 2005.
7. MacGilchrist AJ, Sumner D, Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 13:689-694, 1991.
8. Heller J, Schepke M, Gehnen N, Molderings GJ, Müller A, Erhard J, Spengler U, Sauerbruch, T. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 116:387-393, 1999.
9. Hadoke PVF. Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle. Pharmacol Ther 89:233-254, 2001.
10. Tabernero A, Schneider F, Potenza MA, Randriamboavonjy V, Chasserot S, Wolf P, Mitolo-Chieppa D, Stoclet J-C, Andriantsitohaina R. Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immunolocalization and influence on vascular tone. Intensive Care Med 29:262-270, 2003.
11. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerse NM. Oxidative stress in the blood of patients with alcohol-related liver cirrhosis. Med Sci Monit 8:CR419-CR424, 2002.
12. Adachi T, Togashi HA, Suzuki A, Kasai S, Ito J, Sugahara K, Kawata S. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41:1272-1281, 2005.
13. Fernando B, Marley R, Holt S, Anand R, Harry D, Sanderson P, Smith R, Hamilton G, Morre K. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 28:689-694, 1998.
14. Bomzon A, Ljubuncic P. Oxidative stress and vascular smooth muscle cell function in liver disease. Pharmacol Ther 89:295-308, 2001.
15. Nicholls KM, Shapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, Schrier RW. Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates and suppressibility by central blood volume expansion. Circ Res 56:457-461, 1985.
16. Iwao T, Oho K, Sakai T, Tayama C, Sato M, Nakano R, Yamawaki M, Toyonaga A. Splanchnic and extrasplanchnic arterial haemodynamics in patients with cirrhosis. J Hepatol 27:817-823, 1997.
17. Hadoke PWF, Scotland JJ, Speers GW, Dillon JF, Walker SW, Williams BC, John, TG, Hayes PC. Similarity of response to vasoconstrictors in porcine hepatic and human hepatic and mesenteric arteries in vitro (abstract). Br J Pharmacol 116:412P, 1995.
18. Nielsen H, Mortensen FV, Mulvany MJ. Differential distribution of postjunctional alpha 2 adrenoceptors in human omental small arteries. J Cardiovasc Pharmacol 16:34-40, 1990.
19. Fukui D, Chiba S. Existence of alpha-adrenoceptor subtypes in isolated human gastroepiploic and omental arteries. Circ J 67:259-262, 2003.
20. Salcedo A, Garijo J, Monge L, Sánchez A, Fernández N, García-Villalón AL, Sánchez Turrión V, Cuervas-Mons V, Diéguez G. Endothelium-dependent relaxation of isolated splanchnic arteries from cirrhotic patients: role of reactive oxygen species. Hepatol Res 35:811-819, 2007.
21. Macedo MP, Latu WW. Shear-induced modulation of vasoconstriction in the hepatic artery and portal vein by nitric oxide. Am J Physiol 274:G253-G260, 1998.
22. Ming Z, Han C, Lautt WW. Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction. Am J Physiol 277:G1200-G1206, 1999.
23. Smith REA, Robinson NMK, McPeake JR, Baylis SA, Charles IG, Heaton ND, Moncada S, Williams R, Martin JF. Induction and role of NO synthase in hypotensive hepatic failure. Arterioscler Thromb Basc Biol 17:3079-3082, 1997.
24. Aldasoro M, Martínez C, Vila JM, Flor B, Lluch S. Endothelium-dependent component in the contractile responses of human omental arteries to adrenergic stimulation. Eur J Pharmacol 250:103-107, 1993.
25. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35:478-491, 2002.
26. Battaglia S, Angus P, Chin-Dusting JPF. Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol 21:1189-1193, 2006.
27. Schepke M, Heller J, Gehnen N, Molderings G, Erhard J, Muller A, Spengler U, Sauerbruch, T. The reduced α-adrenergic response of human hepatic arteries in cirrhosis cannot be antagonised by the NO-synthase inhibitor L-NAME (abstract). Hepatology 26:1047, 1997.
28. Stoclet JC, Martinez MC, Ohlmann, P, Chasserot S, Schott C, Kleyschyov AL, Schneider F, Andriantsitohaïana R. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 100:107-112, 1999.
29. Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediated acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol 291:H83-H92, 2007.